WDNA ETF (Wisdomtree BioRevolution Fund) is managed by WisdomTree Investments with $2.5M in net assets. WDNA expense ratio is 0.45%, holding 84 positions across sectors including Health Care, Unknown, Materials. Inception date: 2021-06-01.

WDNA performance shows a YTD return of 11.47%. The 1-year return is 56.52%. WDNA dividend yield stands at 4.20%, paid annually.

WDNA top holdings include Moderna therapeutics (4.4%), Johnson & Johnson (3.1%), Pfizer, Inc. (2.8%), Eli Lilly & Co (2.7%), United Therapeutics Corp (2.7%). View all WDNA holdings, sector breakdown, or dividend history.

WDNA can be compared against other funds using the overlap calculator or side-by-side comparison tool. WDNA alternatives are available via the screener, along with tax-loss harvesting opportunities.